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Summary: Human tissue samples for research. A focus group study in adults and teenagers in Flanders: Attitudes 
towards research on human stored tissue samples may be dependent on the cultural context. To-day, no data exist 
on the attitudes and values of the Flemish population towards such research. To query these attitudes, we conducted 
ten focus groups, composed of adults and of minors on the verge of legal competence. Amongst the focus group 
participants, we found a trust in the advancement of science, and a willingness to contribute tissue to research. 
The importance attributed to informed consent depended on the type of tissue donated and the effort needed to 
contribute. Participants did not see high risk associated with research on stored tissue, but thought there was a need 
for confidentiality protections. The coding of samples was deemed an appropriate protection. With regard to the return 
of research results, people expected to receive information that could be relevant to them, but the meaning of what is 
relevant was different between individuals.
Key-words: Biological sample collections – Focus group – Informed consent – Confidentiality – Biobank – Ethics.
 inTroducTion
The storage and use of human tissue samples for biomedical research 
is much discussed. A substantial corpus of empirical literature exists, 
querying people’s attitudes towards donating tissue for medical re-
search. In the following paragraphs we have included only references 
from 2006 upwards, except for the focus group studies. This literature 
consists of qualitative and quantitative studies, such as surveys (8, 9, 
10, 14, 17, 18, 19, 21), interviews (4, 5), focus group studies (1, 2, 12, 
15, 16, 24, 25) and a review of the empirical literature (26). Themes in-
vestigated and discussed in the literature are attitudes towards research 
(5, 10, 12, 25), willingness to donate (9, 10, 19), commercialization (4, 
5, 12, 17), consent (4, 8, 19, 21, 22, 26), risks (5, 8, 18) and return of 
results (6, 14, 15, 18, 20, 21).
With regard to general attitudes towards research and science and wil-
lingness to participate, studies found that these attitudes were mostly 
quite positive (5, 10). Only cloning was sometimes mentioned as unac-
ceptable (5). One UK study found that medical research had a positive 
image, but that trust was starting to erode (25). With regard to genetic 
research, this study found that the more it was understood, the better 
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it was appreciated. In a study by Levitt, people saw genetic data as 
special (12). Also the willingness to donate tissue was quite high in 
most studies (10, 19). It was linked with the level of trust they had in 
biomedical research (9). 
In an Austrian study, people rejected the idea of being compensated for 
donating tissue, as they saw their donation as an act of solidarity (5). A 
UK study found that some people were worried that they would donate 
freely, but that their donation was used to make money (12). Informa-
tion and consent was seen as more important if the research was done 
for financial gain (17).
It is widely accepted in guidelines and ethical and legal literature (7) 
that the donor or patient whose biological material is used, should 
give informed consent, and that adequate privacy protection measures 
should be put in place. Although it is seen as good ethical practice to 
ask for consent (4), a US study found that people found consent less 
important when anonymous samples were used (8). A meta-analysis 
by Wendler showed that most participants would prefer broad con-
sent (26). A survey of American and Spanish geneticists showed that 
they obtained narrow consent but would prefer to be allowed to obtain 
broad consent (21).
In a US-based study by Ormond, the majority of participants did not 
see any risks associated with biobank research. A minority quoted con-
fidentiality breeches and the risk that insurers and employers would 
access this information (18). Also in the US, Hull found that the pre-
ferences of patients with regard to storage and use of their tissue were 
independent of whether these tissues were kept identifiable or not (8). 
An Austrian study found that there was no real concern about privacy 
protection (5). 
A topic that is still hotly debated in ethical literature is whether resear-
chers should return accidental findings to participants (6). A US-based 
study showed that most would want to have a choice whether to re-
ceive results or not (15). Another US-based study found that a majority 
of participants either hoped for or desired being recontacted with ac-
cidental findings (18). A Japanese study found a high level of positive 
preference for future disclosure of individual genetic results (14). In a 
survey of Spanish and American geneticists, the majority of geneticists 
wanted to inform participants of reliable results (21).
Today, no data exist on the attitudes of the Flemish population towards 
research on stored tissue samples. As such attitudes may be depen-
dent on cultural context we found it useful to query these attitudes and 
opinions (11). Specifically, we discussed attitudes and ethical values 
with regard to research on stored tissue samples, commercialization, 
willingness to donate samples, the importance of informed consent 
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and ethics committees, the risks they saw associated with stored tissue 
samples and the return of research results. Because we wanted to ex-
plore these questions into some depth, and find out whether there were 
any issues that did not come up in the existing literature, we chose 
focus groups as our modus operandi (13). As we did not find any em-
pirical studies based on the opinions of young people on the verge of 
majority, which is 18 in Belgium, we also conducted focus groups in 
this age group.
 maTerials and meTHods
We conducted focus groups to investigate the concerns of a Belgian 
population with regard to research on stored tissue samples. Our study 
group conducted 10 focus groups with a total of 76 participants from 
February 2009 through March 2009. We provided food and beverages, 
so that even when the focus groups were conducted in environments 
such as schools, people would feel relaxed. The focus group with pa-
rents from children with a medical condition was performed online, 
through a chat room, as we thought that the travel distance would be 
an impediment for participation in this group (23). We have provided 
an overview of the different focus groups in table I. We developed 
standard qualitative focus group procedures (13). The topics the mo-
derator (Kristien Hens) introduced during the discussion were the 
willingness to donate samples for biomedical research, the need for 
consent and information, the possible dangers they thought were as-
sociated with such research, the role of ethics committees, the need to 
return incidental research findings. We conducted a pilot focus group 
with specialists in medical law, medical ethics and social sciences, and 
reviewed the discussion guide based on the outcome of the pilot. We 
used three different scenarios: the use of surgical waste, the use of 
blood that was gathered in the context of a medical examination, and a 
longitudinal cohort study (see table II). The scenarios and topics were 
not introduced at fixed moments in the discussion, but as the moderator 
deemed appropriate based on the discussion flow.
The discussion groups were conducted with Kristien Hens (KH) as a 
moderator. Kris Dierickx (KD) was assistant-moderator in most of the 
groups. At the beginning of each discussion, the participants were told 
that the talk was audio taped and that we would process our findings 
in a publishable report. They were assured that this report would con-
tain only anonymous data. No one objected. Audiotapes of the sessions 
were transcribed but not corrected for grammar, in order to capture the 
oral nature of the discussion.
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We used NVIVO8 to do a detailed coding of the transcripts and to 
compare between focus groups and participants. NVIVO is a quali-
tative data analysis software package especially suited for analysis of 
qualitative data such as focus groups transcripts (3). We created cases 
for each focus group participant, with attributes containing demograp-
hic values to allow for comparison between groups and participants. 
During a first-pass analysis, we performed descriptive coding to assign 
each piece of text to a case. During a second pass analysis, we did a 
detailed coding according to the various topics in the text. This part of 
the coding was done by KH and KD separately and then compared to 
match themes. Most groups were quite uniform in their opinions, but 
we have pointed out the most striking differences between groups in 
the results sections. In the rest of this paper, we discuss the findings 
related to attitudes, commercialization, willingness to participate, con-
sent, ethics committee oversight, risks and return of results. 
Scenario Description
Use of surgical waste Imagine a cancer patient undergoing an operation. His 
or her tumor is removed. Afterwards, this tumor can be 
used for research on cancer. Would you consider this 
a good thing? If you were in this situation, would you 
want to be informed about such research? Would you 
want to give permission? Do you see any problems with 
the use of tumors for research?
Use of blood Imagine a routine medical checkup at the doctor’s 
office. This checkup requires some blood to be drawn 
for analysis. The doctor asks whether he or she can draw 
some extra blood that is to be used for research. Do you 
think this scenario is different from the previous one? 
Would you mind that your blood is used? Would you 
want to know about such research? Would you put any 
restrictions on the type of research that can be done on 
this blood?
Longitudinal study Imagine a study that follows participants over a period 
over several years. Research participants are asked to 
yearly give some blood for research and to undergo 
some medical examinations and some tests, such as an 
IQ test. This research is done for the advance of science 
not to know about the health of participants. Do you 
think such research is useful? Would you participate to 
such research? Under which conditions? 
Table II: Overview of scenarios and associated questions
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 resulTs
ATTITUDES AND COMMERCIALIZATION
All focus group participants thought that research on stored tissue sam-
ples was useful: they quoted the discovery of new medicine, as well 
as fundamental research on the functioning of DNA and genes and the 
development of cancer cells. The uses of human biological materials 
that were seen as unacceptable were, apart from cloning, outside of 
the biomedical sphere and included biological warfare and consumer 
products such as cosmetics. Although we did not specifically introduce 
the topic of commercialization, this was a topic that came up sponta-
neously, except for two of the five teenager focus groups. With regard 
to the use of their own tissue by pharmaceutical companies, reactions 
ranged from indifference to reluctance. People holding the latter atti-
tude would prefer to donate to universities. However, the same people 
often came to the conclusion that commercial research might also be 
necessary for the advance of science. There was some fear about ex-
cesses if pharmaceutical companies performed biomedical research: 
patenting should not stall research or make innovations inaccessible 
to patients. Also, people thought it acceptable that companies would 
make money out of a scientific finding based on samples, but not out 
of the direct selling of a sample. 
WILLINGNESS TO PARTICIPATE AND CONSENT
All participants would agree to the use of leftover tumors for research, 
but were divided on whether this could be used with or without con-
sent. One line of thought was that it was not needed to ask permission, 
as it would be thrown away otherwise. Another view was that resear-
chers should ask it anyway, out of politeness, as donation might be 
against someone’s religious beliefs. But others expressed the fear that 
if such permission was asked, some people would refuse and hence 
valuable material would get lost.
In this scenario, the line between information and consent was dif-
ficult to draw: On the one hand, participants believed it was good that 
patients knew that their tumor would be used for further research, to 
aid other people. On the other hand, participants also feared that such 
patients would be burdened by too much information.
The second scenario we dealt with was the collection of an ‘extra tube 
of blood for research’, in the context of a routine medical checkup. 
This was considered different from the tumor, although participants 
found it hard to specify why. They agreed almost unanimously that if 
163
K. Hens et al., Human tissue samples 
an extra tube of blood was taken for research, consent should be sou-
ght. But many participants were also willing to contribute to this type 
of research. In this scenario many participants would like to receive 
further information about the type of research. The more trustful parti-
cipants, however, stated that they would equally well donate blood in 
this case, regardless of the type of research that was performed. 
When participants reflected on the third scenario, of a longitudinal re-
search on biobank samples, all participants in all focus groups agreed 
that this would have to be on a voluntary basis. But also here, there 
was willingness to participate. Those unwilling were not adverse to the 
research as such, but were afraid it would cost them too much time, 
or thought punctures were too troublesome to have done on a regular 
basis. 
EThICS COMMITTEE OVERSIGhT
There was a consensus hat ethics committee supervision of research on 
stored tissue samples was a good thing. Participants would be willing 
to rely on the opinions of ethics committees to decide on the usefulness 
and acceptability of research. The fact that they would know that an 
ethics committee was involved was felt to be a reassurance. The task 
of such ethics committee would not only be to decide on the accepta-
bility of research, but, some thought, also to prioritize and to decide 
which research is more important and should be performed first. In 
one adult focus group, people would even accept surrogate decision 
making by ethics committees, and hence were willing to delegate their 
responsibility to decide which research was acceptable or not. In the 
other groups, this was less pronounced. As for the members of ethics 
committees, there was consensus that these should consist of medical 
experts, but some also mentioned lawyers, ethicists, lay people and 
representatives of different religions. 
RISKS ASSOCIATED WITh RESEARCh ON 
STORED TISSUE SAMPLES
Apart from the fact that some participants did not like venepunctu-
res, people did not associate too much risk with research on stored 
tissue samples. If risks were quoted, they were related to privacy is-
sues. People thought there should be some assurance that only the re-
searchers could access the data. In a focus group with teenagers, the 
suggestion was made that some people would be ‘ashamed’ if they had 
a disease such as AIDS and this would be widely known. Employers 
and insurance companies were sometimes mentioned as instances that 
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should not have access to medical information and biological samples. 
Also, there was fear that representatives of pharmaceutical companies 
and even supermarkets would use these data for targeted marketing. 
But participants did not have problems with sharing medical informa-
tion next to biological samples with biomedical researchers. 
We discussed the link between traceability of biological samples and 
medical data and confidentiality. For more distrustful participants, ano-
nymization was a requirement for participation, as this would be an 
absolute guarantee that no information could be leaked to third parties 
such as insurance companies. But it was acknowledged that anonymi-
zation did have some drawbacks: researchers would not be able to con-
tact participants for further background information and if something 
relevant to the participant was found, there was no way this could be 
returned. 
In the majority of the focus groups, the solution of coding was sponta-
neously suggested as an acceptable middle ground between total ano-
nymization and complete identifiability. 
RETURN OF RESULTS
One topic that was discussed in some depth in most of the focus groups 
was whether researchers would have the duty to return incidental fin-
dings to participants. On the one hand, people accepted that there is a 
clear distinction between research and diagnosis, and that the focus of 
the former is not to provide diagnostic information to individual parti-
cipants. On the other hand, returning results was considered the more 
humane option. Also, returning personal results was sometimes seen as 
a kind of compensation for the effort of participating research. There 
was much disagreement, however, about which types of results should 
be returned. There was some consensus that preventable and treatable 
conditions should be told. In this context, contagious diseases such 
as AIDS were quoted. However, when an example such as Alzheimer 
came up, there was disagreement whether people wanted to know this 
or not. Some groups concluded that it might be best to ask donors and 
patients whether they would want results or not, and even which type 
of results they wanted. 
Participants also discussed the possibility of receiving general (non-per-
sonal) research results. Reactions ranged from indifference to whether 
they received such information or not to appreciation. Appreciation 
was linked to being more motivated and to being able to feel proud if 
people knew to which research they had contributed. Especially in the 
focus group of representatives of patient organizations it was stated 
that in any case these results should be understandable for lay people. 
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 discussion 
As a whole, we found a strong interest in science and a strong feeling 
of commitment. People used terms as pride and curiosity when they 
referred to their potential donation to scientific research. Belgium is 
a welfare state with a well established social security system and has 
been unaffected by scandals in medical practice or medical research, 
which can explain the trust in science we found. This is also consi-
stent with studies in countries such as Sweden and Austria (5, 10), and 
slightly different from studies in the UK, which has recently been af-
fected by the Alder Hey scandal (25). The view of science as some-
thing which is linearly progressing is similar to what Felt describes, 
with a reference to Godin, as a linear flow of progressing innovation, 
to benefit humankind and create better futures (5). As she describes, 
this is linked with a high willingness to donate tissue. The fact that 
most of our participants were not completely negative to the use of 
samples by pharmaceutical companies might also be linked to this. On 
the one hand, non-profit research in universities and hospitals is seen 
as being at the core of the medical practice, with first right of access 
to samples. On the other hand, pharmaceutical companies, which are 
companies that function within the same medical practice, are consi-
dered as valuable for progress as well. Mary Dixon-Woods speaks in 
this respect of a mixed economy (4). People agreed that uses that fall 
outside of medical practice, such as cosmetics and direct marketing, 
were not acceptable.
Broadly, we could identify ranges from extremely trustful people to 
people that were less trustful and had some reservations. People from 
the first category were typically happy to contribute to any kind of re-
search, would not mind tissue being used even without consent, would 
not mind identifiable samples to be used, saw no risk associated to 
research and were happy to rely on ethics committees for ethical deci-
sion making. Informed consent and information were seen as a ‘nice to 
have’. People from the latter category would prefer anonymous sam-
ples, as they had greater fear that third parties would gain access to and 
misuse information derived from biological samples. They attributed 
greater importance to informed consent in comparison to surrogate de-
cision making by ethics committees. But still, they had a fairly high 
confidence in science and scientists as such. Most participants fell in 
between these two categories.
With regard to the tasks of informed consent, our findings were consi-
stent with other empirical studies that query the task of informed con-
sent (5, 12). Informed consent was not primarily aimed at the need to 
make an informed choice based on risk, although for the participants 
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that belonged to the category ‘distrustful’ this also played a role. The 
fact that scientists would ask permission or at least give information 
was considered overall as positive, and a sign of ‘respect’ but more so 
in scenarios two and three. This was linked to the higher level of ef-
fort that people thought was required in these cases. With regard to the 
need to consent for residual materials, opinions were divided. Overall 
information and consent were seen as a nice to have: people would not 
mind leftover materials to be used, but would also be curious about 
research performed on these materials. However, for some of our more 
distrustful participants, consent was also an absolute requirement in 
the case of residual materials. 
Participants did not see much danger in contributing tissue and medical 
data for research. Risks quoted were linked with confidentiality issues, 
the use of that data by third parties such as employers and insurers, and 
sometimes the fear of being associated with a certain disease. This is 
analogous with existing empirical data that quote breach of privacy, 
confidentiality & reputation (8, 15, 18). The solution of coding sam-
ples and data, as was spontaneously suggested, was thought sufficient 
to protect against these risks. 
With regard to returning of results, the fact that people would receive 
general research results, or could enroll to receive such information, is 
perceived as positive, which is consistent with a UK study that found 
that most people like to receive such results (8). With regard to the 
return of individual results, the discussion is somewhat more difficult. 
Although people are aware that medical research is for the benefit of 
future patients, there seems to be an expectation that important findings 
are communicated to the afflicted donor. This is consistent with empi-
rical studies in other countries (14, 18, 21). However, it was unclear 
exactly which findings should be returned: this ranged from anything 
that might be significant to only contagious diseases such as HIV. 
Participants in the teenage groups showed a great confidence towards 
scientists and a great trust that science is useful. They also showed 
much curiosity in research findings. The teenagers were overall not 
much concerned with privacy protections, and did not mention the risk 
of unauthorized access by insurers or employers. The greatest privacy 
concern that was voiced in these groups was that of stigmatization, of 
people being ashamed of having a certain disease.
We acknowledge that our study has several limitations. We had a very 
small number of participants in focus groups FG4 (members of patient 
organizations) and FG8 (parents of children with a medical condition), 
and a small number of males (7 males – 28 females) in the focus groups 
with adults which made our study sample somewhat unbalanced. Also, 
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given the qualitative nature of our study our findings can probably only 
hint at what lives in the minds of the Belgian population. Ideally, such 
study is followed by a larger population-wide quantitative study, which 
would allow more detailed analysis of differences between categories 
of people. However, given the fact that this is the first study of opinions 
about the subject in Flanders, and of the opinions of teenagers on this 
matter, and that we got fairly homogenous responses, we think that it is 
a good ‘first step’. The fact that it is a focus group study, on a voluntary 
basis, also implies that the participants might have been biased, either 
in the positive or the negative sense, and is probably not representative 
of the Flemish population.
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